Qualcomm Life

By Jonah Comstock January 21, 2016
According to a report in Bloomberg, GlaxoSmithKline is in talks with Qualcomm to create a new joint venture to develop medical technology. Financial Times added in its report that the JV could be worth up to $1 billion. Very little information about the prospective partnership is available, but it makes sense for both companies: Qualcomm has already teamed up with both Roche and Novartis on major...
By Aditi Pai January 6, 2016
Novartis has announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler, for people who have COPD. Specifically, Qualcomm Life will develop the reference design for the module that will connect the Breezhaler to the Qualcomm Life 2net platform, a hub for connecting home health devices. This platform will collect data on inhaler...
By Aditi Pai November 10, 2015
Walgreens announced that it expanded its telehealth offering, which the company launched in partnership with MDLive last year, to 20 more states. The telehealth service is now offered in 25 states total -- after launching with two, it added another three in June. The company also announced the launch of a new app, called Walgreens Connect, in partnership with Qualcomm Life that allows Walgreens...
By Jonah Comstock October 22, 2015
The FDA has cleared SmartLinx Vitals Plus, a mobile-connected in-hospital patient monitoring system from Qualcomm Life subsidiary Capsule. It received FDA 510(k) clearance for prescription use as a class II medical device. Qualcomm Life completed the acquisition of the French company just last month. On its website, Capsule describes Vitals Plus as "an innovative patient monitoring system that...
By Jonah Comstock September 14, 2015
Qualcomm Life, the mobile technology company's subsidiary focused on medical device connectivity, has acquired Capsule Technologie, a France-based clinical data management company that currently serves 1,930 hospital clients in 38 countries, for an undisclosed amount. Up until now, Qualcomm's focus has been on connecting the data from home healthcare devices back to the hospital. But with the...
By Aditi Pai May 6, 2015
Japanese medical device company Omron Healthcare has unveiled two new smartphone-connected devices, a blood pressure monitor and a weight scale. These offerings are designed to be used as part of a telemedicine program -- the products are listed on Omron's new Global Telehealth Portal website, which launched this month. "These easy to use devices allow chronically ill patients the freedom to...
By Jonah Comstock April 13, 2015
Since Walgreens merged with UK drugstore chain Boots last year, the company has been ramping up its digital strategy and has announced a slew of strategic partnerships with companies like Qualcomm Life, WebMD, MDLive, and PatientsLikeMe. Walgreens President and Walgreens Boots Alliance EVP Alex Gourlay, who transitioned over from Boots in the merger, spoke at HIMSS this week in Chicago about each...
By Jonah Comstock January 29, 2015
Less than a month after announcing its partnership with Novartis, Qualcomm is adding another big pharmaceutical company to its list of 2net partners: Roche, who will use Qualcomm Life's 2net platform to capture patient data from connected devices, starting with anti-coagulation meters. “This collaboration marks a significant milestone for Roche as we launch a new generation of point-of-care...
By Jonah Comstock January 8, 2015
Qualcomm's 2net Hub Qualcomm Life announced two major partnerships at CES15 this year: one with pharmaceutical company Novartis and the other with pharmacy chain Walgreens. Novartis selected Qualcomm Life as a partner for its global Trials of the Future program, in which Novartis is endeavoring to use more mobile technology in its clinical trials and to provide connectivity for future Novartis...
By Jonah Comstock May 22, 2014
San Juan Capistrano, California-based remote monitoring analytics company Jointly Health has raised $1.3 million from investors including Frost Venture Partners and Reed Elsevier Ventures. This brings the company's total funding to date to $3.8 million. According to CEO Dean Sawyer, the company's first product is still awaiting FDA 510(k) clearance, but they have their first few health plan...

Editor's Pick